Mutation scanning in Marfan syndrome using High Resolution Melt analysis Kate Sergeant, Northern Genetics Service, Newcastle upon Tyne.

Slides:



Advertisements
Similar presentations
Lecture 3 Strachan and Read Chapters 16 & 18
Advertisements

Applications of HGP Genetic testing Forensics. Testing for a pathogenic mutation in a certain gene in an individual that indicate a persons risk of developing.
Implications of Consanguinity for Routine Diagnostic Testing and Development of Specialist Services Teresa Lamb Clinical Scientist Leeds DNA Laboratory.
Kate Thomson Molecular Genetics Laboratory, Oxford
Clinical background: Patient RM, YoB 1966 Her family were originally referred because of a history of breast and ovarian cancer. BRCA testing found a missense.
Marfan Syndrome: Mosaic Case Study
Validation of BRCA2 mutation scanning using the LightScanner system for high resolution melt analysis Lewis Darnell Nottingham Regional Molecular Genetics.
By: Tyler Abel. Cardiovascular System  Enlarged Aorta (blood flow away from the heart)  Aorta tearing (separation of layers)  “Floppy” mitral valve.
Development of a BRCA2 screening service – Introduction of high resolution MELT analysis A Grade Trainee Project Nick Camm Yorkshire Regional Genetics.
Assessment of a high-throughput DNA melting analysis assay for rapid screening of gene variants in the ornithine transcarbamylase gene K. Sumner*, L. Hubley*,
Polymorphisms: Clinical Implications By Amr S. Moustafa, M.D.; Ph.D. Assistant Prof. & Consultant, Medical Biochemistry Dept. College of Medicine, KSU.
Diagnostic Testing for Familial Pancreatitis Emma McCarthy Clinical Scientist Merseyside & Cheshire Regional Molecular Genetics Laboratory.
Mutations Section 12–4 This section describes and compares gene mutations and chromosomal mutations.
Genetic Diseases Autosomal Recessive Diseases – PKU (phenylketonuria) caused by a recessive allele found on Chromosome 12 Causes accumulation of phenylalanine.
Genetic Testing for Wilson Disease Melissa Dempsey, M.S., CGC The University of Chicago Genetic Services Laboratory July 17, 2010.
What Can You Do With qPCR?
Mitochondrial DNA maintenance disorders Carl Fratter Oxford Medical Genetics Labs.
Modified Allele Dosage (MAD) Genotyping by Hi-Res Melting  of Whole Amplicons Jason T. McKinney Scientist Human Genetics Applications.
KEY CONCEPT Genetics provides a basis for new medical treatments.
Student name. Marfan syndrome is a genetic disorder that affects the development of connective tissues in the body. Marfan Syndrome.
The LightScanner ® System Achieve High Throughput Mutation Discovery and Genotyping.
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
Establishment of a screening service for Bethlem Myopathy and Ullrich Congenital Muscular Dystrophy Tom Cullup Guy’s Hospital DNA Laboratory.
Investigating the use of Multiple Displacement Amplification (MDA) to amplify nanogram quantities of DNA to use for downstream mutation screening by sequencing.
Evolutive particularities of cardiovascular disorders in children with Marfan Syndrome First author: Adriana Crăciun Second authors: Aurica Crea, Iulia.
Genetic Disorders, Part Deux
A Novel Approach for Unique MRD Markers Identification in Acute Leukemia Patients Tereza Jančušková synlab genetics s.r.o. Evropska 176/16, Prague, Czech.
Jonathan Callaway Wessex Regional Genetics Laboratory
A Diagnostic Testing Service for Hypophosphatemic Rickets
Development of Molecular Methodologies for the Enhanced Detection of Tumour Biomarkers Michelle Wood, Hood Mugalassi, Justyna Tull, Linda Meredith, Rachel.
PCR assay of intragenic mutation lesions induced by monoenergetic fission neutrons and gamma rays in Drosophila Part I: Gamma rays Nanette Brand 1 Nonhlanhla.
Molecular Genetics in the Von Willebrand disease Ghasem Rastegarlari.
Unit 2-5 Notes Mr. Hefti – Pulaski Biology Genetic Testing.
ASARE SMART TOPIC; MARFAN SYNDROME.. INTRODUCTION. Marfan syndrome is a disorder of the connective tissues of the body, manifested principally by changes.
The Factor II (Prothrombin) G20210A Detection and Genotyping
By: Alaina Zsampar MARFAN SYNDROME.  Disorder that affects the body’s connective tissues  1896  By French Doctor Antoine Marfan  Observed a five year.
HRM Assay and Optimization 1. DNA Quality 2. Amplicon LengthAmplicon  lengths of 100–300 bp 3. Primer Selection 4. Dye Selection 5. MgCl2 Concentration.
Mutational Spectrum in Egyptian CAH Patients
Molecular Genetics and Diagnosis of SSADH deficiency
Genetic Diseases Autosomal Recessive Diseases
Marfan Syndrome By Jared Bowen-Kauth.
Annabelle’s Challenge is a UK registered charity with a brave little girl at its heart; eight-year-old Annabelle Griffin. Annabelle was diagnosed with.
Marfan Syndrome Melanie Dragomire Dr. Williams NS215
Fig. 2. High-resolution melting curves for exon 21 of the EGFR gene
Development of a next-generation sequencing gene panel for neurogenetic disorders J E Martindale, R Crookes, L Crooks, N J Beauchamp, A Dalton Sheffield.
Keyur P. Patel, Bedia A. Barkoh, Zhao Chen, Deqin Ma, Neelima Reddy, L
Copyright © 2011 American Medical Association. All rights reserved.
From: Comparison of High-Resolution Melting Analysis with Denaturing High-Performance Liquid Chromatography for Mutation Scanning in the ABCA4 Gene Invest.
Marfan’s Syndrome By Emily Espinosa.
Genetic Testing Result Means. Before Genetic Testing  The result of genetic testing can be life changing.  It is important for patients and their families.
KEY CONCEPT Genetics provides a basis for new medical treatments.
KEY CONCEPT Genetics provides a basis for new medical treatments.
KEY CONCEPT Genetics provides a basis for new medical treatments.
Design and Validation of a Conformation Sensitive Capillary Electrophoresis-Based Mutation Scanning System and Automated Data Analysis of the More than.
Keyur P. Patel, Bedia A. Barkoh, Zhao Chen, Deqin Ma, Neelima Reddy, L
Station 2 Protein Synethsis.
Feocromocitoma y Paraganglioma
Application of COLD-PCR for Improved Detection of NF2 Mosaic Mutations
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes  Eduardo.
Validation of High-Resolution DNA Melting Analysis for Mutation Scanning of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene  Marie-Pierre.
KEY CONCEPT Genetics provides a basis for new medical treatments.
KEY CONCEPT Genetics provides a basis for new medical treatments.
Patient carrying two probably damaging missense variants in HCFC1 and ATRX: one causative mutation and one modifier variant? (A) Family tree of patient.
KEY CONCEPT Genetics provides a basis for new medical treatments.
Identification of a New Splice Form of the EDA1 Gene Permits Detection of Nearly All X- Linked Hypohidrotic Ectodermal Dysplasia Mutations  Alex W. Monreal,
BRCA2 exon 2 Lightscanner – normal sensitivity setting (duplicates)
Rapid Detection of HIV-1 subtype C Integrase resistance mutations by the Use of High-Resolution Melting Analysis Tendai Washaya BSc, Msc. Pre-PhD Student.
Human Genetic Disorders, Part 2
Presentation transcript:

Mutation scanning in Marfan syndrome using High Resolution Melt analysis Kate Sergeant, Northern Genetics Service, Newcastle upon Tyne

Marfan syndrome Autosomal dominant, 1 in – 1 in Autosomal dominant, 1 in – 1 in Connective tissue disorder Connective tissue disorder Affects ocular, skeletal & Affects ocular, skeletal & cardiovascular systems – risk of sudden death cardiovascular systems – risk of sudden death FBN1 chr 15, 65 exons FBN1 chr 15, 65 exons 350 kDa extracellular matrix protein Fibrillin 350 kDa extracellular matrix protein Fibrillin

FBN1 mutations Over 600 reported mutations (UMD-FBN1) Over 600 reported mutations (UMD-FBN1) Most mutations are unique Most mutations are unique Most pathogenic mutations are missense affecting cysteine residues Most pathogenic mutations are missense affecting cysteine residues Mutation analysis of FBN1 exons detects ~80% Mutation analysis of FBN1 exons detects ~80% Identifying a mutation gives a definitive diagnosis – cardiological screening to those at risk Identifying a mutation gives a definitive diagnosis – cardiological screening to those at risk

Aims Set up an assay for mutation scanning in FBN1 Set up an assay for mutation scanning in FBN1 Using the LightScanner High Resolution Melt (HRM) analysis system for heteroduplex detection Using the LightScanner High Resolution Melt (HRM) analysis system for heteroduplex detection Validate this method using positive controls Validate this method using positive controls Test Marfan syndrome patients for FBN1 mutations Test Marfan syndrome patients for FBN1 mutations

+ LightScanner HRM system

HRM analysis Temperature Fluorescence variant Temperature  Fluorescence

FBN1 assay design

Validation with positive controls

Results Exon 2 c.247+1G>A het Exon 43 c A>G het Exon 57_2 c C>A het Exon 29 c.3609_3610ins13 het

Results c.7852G>A63 c.4038C>G32 c C>A57 c.3963A>G31 c.6888G>A56 c.3609_3610ins1329 c.6817A>G55 c.3511T>C28 ( ) c A>T54 c.2684_2689del622 c.6594C>T53 c.2559C>A21 c.5816G>A47 c.2023_2026delTTTG16 ( ) c G>T46 c.1875T>C15  c dupT45 c.1793insTT14 c A>G43 c.1122delT9 c _4942+9del739 c.772C>T7 c.4588C>T37 c.718C>T6 c.4408T>C35 c A>G5 c.4270C>G34 c.306T>C3 c.4139G>A33 c.247+1G>A2 Identified? Nucleotide changeExon Identified? Nucleotide changeExon

Exons 46 and 54 – false negatives? c G>T het wild type Exon 46 c G>T het wild type ?

Exon 45 – false negative c dupT het Exon 45

Exon 45 – larger sample number c dupT het

False positives 22 false positives were encountered 22 false positives were encountered Problem with archived DNA and different extraction methods Problem with archived DNA and different extraction methods Reduce this by Reduce this by Standardising extraction methods Standardising extraction methods Dilute DNA samples in a common buffer Dilute DNA samples in a common buffer Double reaction volume Double reaction volume

Summary of validation 28 positive controls tested 28 positive controls tested 1 “true” false negative 1 “true” false negative 22 false positives 22 false positives  Sensitivity ~ 96%  Specificity ~ 94%

Patient panel 6 patients tested so far 6 patients tested so far Correctly identified 12 SNPs Correctly identified 12 SNPs Reduced number of false positives Reduced number of false positives  Specificity ~98%

Conclusions + Sensitive + Quick + Low cost  False positives  Different DNA samples  Some user variability Suitable scanning technique for a large gene

Acknowledgements All in the Newcastle laboratory All in the Newcastle laboratory David Bourn David Bourn Claire Healey, Val Wilson & Danny Routledge Claire Healey, Val Wilson & Danny Routledge Salisbury laboratory – Catharina Yearwood Salisbury laboratory – Catharina Yearwood